RE: Exciting prospect25 May 2020 13:22
Where we stand now?The Company had received delivery of the initial quantity of the Covid-19 plasmid DNA from the National Institute for Health ("NIH") in the USA and has appointed Evotec International Gmbh ("Evotec") to undertake the Nuvec® proof of concept work for use with Covid-19 at its site in Toulouse, France.
It seems the update from Evotec should be around first week of June on success we are looking for another 4 months to complete the three stages outlined in the last RNS..and at the same time results from the collaboration with Nanomerics should be in hand. All are awaiting news UK Innovate Ltd, EUNCL and NIH USA which proves my point that race of the Vaccine is on Nuvec as delivery system is well placed in the coming weeks. I wonder how we stand with Astra Zeneca as in the past with grant provided by Innovate Ltd.